Bruker Corporation

Bruker Corporation develops, manufactures, and distributes scientific instruments and analytical solutions globally. It operates through four segments: BSI BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers a range of products, including life science tools, mass spectrometry systems, diagnostic kits, research instruments, and portable detection systems.

Overview

Sector

Medical Devices

Target Price

14.8 NOK

Current Price

42.7 NOK

Potential

14%

Strengths

Price to book ratio (2.12) is lower than the sector mean (13.90).

Weaknesses

With a depreciation Potential of -100.00%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.
The company has high debt. Net Debt to EBITDA Ratio (3.44) is higher than the sector mean.
The Price to Free Cash Flow ratio (375.32) is significantly higher than the sector mean.

Indicator	Value
PER	46.1
EV/EBITDA	14.7
Price/Free Cash Flow'	90.3
ROIC	18.5%
Net Debt/EBITDA	0.1

Bruker Corporation

Overview

Strengths

Weaknesses

Key Financial Data